Summary The properties of a new tumour cell line (NB 1 -G) derived from human neuroblastoma by xenografting in nude rats followed by adaptation to tissue culture are described. Studies (Carachi et al., 1983) . Survival for this group is only 15-20% even after the most aggressive therapy. New approaches to treatment are evidently required and might be investigated using appropriate laboratory models. In this paper we describe the biological and radiobiological properties of a new cell line (NB 1-G) derived via xenografting from human neuroblastoma. This cell line may be grown in conventional monolayer culture or as multicellular tumour spheroids.
Neuroblastoma is a malignant tumour of neural crest origin. It is the most common extracranial malignant solid tumour in childhood and accounts for 10% of childhood malignancies (Jaffe, 1976; Breslow & McCance, 1971) . Abdominal neuroblastoma accounts for 70% of all sites and presents clinically at a late stage (Carachi et al., 1983) . Survival for this group is only 15-20% even after the most aggressive therapy. New approaches to treatment are evidently required and might be investigated using appropriate laboratory models. In this paper we describe the biological and radiobiological properties of a new cell line (NB 1-G) derived via xenografting from human neuroblastoma. This cell line may be grown in conventional monolayer culture or as multicellular tumour spheroids.
Materials and methods
Origin of the tumour The patient presented in 1979 aged 18 months with an abdominal mass and a right pleural effusion. At laparotomy, a large retroperitoneal haemorrhagic tumour was found arising from the right suprarenal region. The tumour crossed the midline and infiltrated the diaphragm. The liver was free of disease. A biopsy was taken which confirmed the presence of a neuroblastoma which was considered to be Stage IV. The pleural effusion was tapped and found to be full of neuroblastoma cells. Both solid tumour from the biopsy and cells from the pleural effusion were taken for xenografting. The patient died in the early post-operative period before any therapy could be instituted.
Xenograft procedure Tumour fragments from the biopsy were aseptically implanted in nude rats using a wide bore needle. The procedure entailed the needle entering at the right flank then being tunnelled to the right axilla where the tumour fragment was deposited. This reduces tumour loss, and also facilitates vascularization from the axillary vessels. This led to the development of a viable transplantable tumour as described below. (Cells from the pleural effusion were implanted i.p. but did not result in tumour growth.)
The latent period before detectable tumour growth was 11 weeks. Thereafter the tumour grew from 0.5 cm diameter to 3 cm in a period of 3 weeks. The tumour was passaged 17 times in nude rats before storage in liquid nitrogen. During this time, the morphology of the tumour by light microscopy and EM remained similar to that of the original tumour in the patient. In 1984 the tumour line was successfully recalled and passaged once in nude rats. The tumour was surgically excised, minced and disaggregated by digestion with trypsin followed by vigorous pipetting. The resultant tumour cell suspension was then taken for in vitro studies. Cytogenetic studies These studies were carried out using NB1-G cells in monolayer. Twenty-four hours after subculturing, cells were treated with colcemid as an arresting agent for h then shaken off, centrifuged and treated with hypotonic solution (serum-free RPMI 1640 diluted with distilled water 1:4) for 6 min at room temperature. Cells were centrifuged and fixed in three changes of 1:3 acetic acid:methanol. Spreads aged 4-6 days were banded by the SSC-trypsin-Giemsa method (Gallimore & Richardson, 1973) .
Monolayer
Monoclonal antibodies The cells were tested for antigen specificity using a panel of monoclonal antibodies including those used in the differential diagnosis of neuroblastoma from Ewing's sarcoma and rhabdomyosarcoma (Sugimoto et al., 1985) . The full panel is specified in Table I . Cells were harvested using trypsin and washed twice in PBS. Cells (5 x 105 -1 x 106) were incubated with each for 30 min at 4°C in antibody excess. After washing, binding of antibody was detected using fluorescein-conjugated F(ab)'2 goat antimouse immunoglobulin (Ig), previously affinity-purified and absorbed with human Ig and pig liver powder. Samples were examined with a Zeiss photomicroscope III with epiillumination optics.
In situ DNA hybridization A study was carried out to test for the presence of the Nmyc gene. 1 Mg of the N-myc probe p Nb-I was labelled with 3H by nick translation to specific activity of 10-7dpm using all four 3H labelled deoxynucleotide triphosphates (Amersham International plc) and hybridized in situ to chromosomes of NB1-G prepared as described above using the methods described previously (Mitchell et al., 1985) . The slides were dipped in Ilford L4 nuclear emulsion and exposed at 4°C for 10 days before developing and staining as previously described (Joseph et al., 1984) .
Southern blot analysis Genomic DNA was prepared by a standard method (Maniatis et al., 1982) . Samples were digested with Eco RI, electrophoresed through 0.8% agarose and blotted onto nitrocellulose (Southern, 1975) . Filters were hybridized with nick-translated 32P-labelled p Nb-I DNA (0.1 pg of specific activity 2 x 108 cpm pg-1) (Rigby et al., 1977 Twentyman, 1982) . The measured areas were converted to volumes, assuming spherical geometry and growth curves constructed by taking median spheroid volume for each experimental group on each day of measurement. The size range covered the growth curve observations (250 rM-1,000 pM diameter) corresponding -very roughly -to an increase in cell number of from '-5 x 102 to -3 x 104 cells.
Results

Monoclonal antibody studies
The results of testing NBI -G cells against the panel of monoclonal antibodies are summarized in Table I . As may be seen, the cells display a predominantly neuro-ectodermal pattern of specificities. By these criteria, previously used in the differential diagnosis of neuroblastoma from Ewing's sarcoma and rhabdomysarcoma (Sugimoto et al., 1985) , NB1-G cells are considered to have antigenic specificities typical of a neuroblastoma.
Chromosome analysis The quality of chromosome preparations obtained was not good and relatively few cells could be analysed fully. The modal number of chromosomes was 49. The distribution of chromosome number in 27 cells scored was 45(1), 46(2), 47(5), 48(5), 49(12), 50(2). A number of abnormal chromosomes were observed. In every cell stored there were three copies of chromosomal, all abnormal: one with an extra dark and light band at the top of Ip and two with large HSRs on the distal end of lp. These HSRs were not strictly 'homogeneously staining regions', having some closely apposed dark and light bands in some cells. This is in agreement with other reports of HSRs. An abnormal chromosome 16 was observed in almost every cell examined. Trisomy 6 occurred in at least 75% of cells and trisomy 7 in 50%. A typical karyotype is shown in Figure 1 . There were some other apparently random abnormalities.
In situ DNA hybridization Figure 2 shows the autoradiograph of a typical cell after hybridization in situ with pNb-1. Both chromosomes 1 carrying HSRs show heavy labelling within the HSR. However the label is not distributed uniformly over the whole region in either chromosome but is restricted to a relatively small area and it appears that the HSRs contain other sequences as well as the amplified N-myc genes. This may be similar to the HSR in the neuroblastoma cell line IMR-32 which contains amplified sequences derived from other regions of the chromosome 2 short arm (Shiloh et al., 1985) .
Southern blot analysis A panel of serial dilutions of Eco RI digested DNA from the neuroblastoma cell line NB1-G were probed with the N-myrspecific probe pNb-l (Schwab et al., 1983t . The inten-sity of the resulting signals were compared with those of Eco RI digested placental DNA samples which were used as controls (Figure 3 ). All samples tested showed the presence of a hybridising Eco RI restriction fragment of -2.1 kbp as predicted from the restriction map of the human N-myc locus (Schwab et al., 1983) . The intensity of the signals seen in the placental DNA samples were the same as those obtained in hybridizations done on numerous fresh tissue and blood DNA samples (data not shown) and therefore represents the normal copy number of the N-myc gene. The estimated amplification factor of the N-myc gene locus in the cell line NBI-G is -20-30 (Figure 3 ).
Radiobiological studies Growth curves for control and irradiated spheroids are shown in Figure 4a . There is a progressive displacement of growth curves to the right as the radiation dose increases. Attempts were made to deduce 'in situ cell survival curves' from these spheroid growth data by extrapolation of the regrowth curves to zero time. The rationale for this procedure has been considered elsewhere (Wheldon et al., 1985) . A calculated curve was obtained relating the radiation dose to the estimated surviving fraction of cells in the spheroids of each experimental group, and is depicted in Figure 4b . A computer fit was made of the multitarget function Shiloh et al., 1985) . Quantitative analysis by Southern hybridization shows about 24 fold amplification of the Nmyc oncogene in NBI-G. The existence of HSRs and of the amplified N-myc gene are similar to that reported for other neuroblastoma cell lines and are features which may be associated with tumour progression .
The radiobiological studies demonstrate that NBI-G cells grown as spheroids are moderately radiosensitive with survival curves indicative of little or no capacity for repair of sublethal damage. Parallel studies on radiosensitivity of monolayer cells would be of interest but have so far been prevented by difficulties in obtaining discrete colony formation by NBI-G cells. However, it is likely that tumour spheroids provide the more realistic in vitro model of human cancer. These in vitro observations provide experimental support for the clinical strategy of treating neuroblastoma using hyperfractionated radiotherapy (Deacon et al., 1985; Wheldon et al., 1985; 1986) . Other radiobiological studies to which NBI -G cells lend themselves include experimental treatment by radioisotopes immunologically targeted by monoclonal antibodies or biochemically targeted by means of the catecholamine precursor MIBG (Treuner et al., 1984) . More generally, the retention of specific tumour properties by cell lines in vitro provides encouragement that lines such as NBI-G should be useful both for fundamental studies on human cancer and for experimental investigation of alternative approaches to therapy.
